Letter to the Editor
Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia
¿Por qué elegir ciclosporina A como primera línea terapéutica para la neumonía causada por COVID-19?
Read
15214
Timeswas read the article
2241
Total PDF
12973
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 April | 75 | 10 | 85 |
| 2024 March | 103 | 30 | 133 |
| 2024 February | 100 | 53 | 153 |
| 2024 January | 66 | 36 | 102 |
| 2023 December | 74 | 52 | 126 |
| 2023 November | 89 | 47 | 136 |
| 2023 October | 102 | 42 | 144 |
| 2023 September | 179 | 57 | 236 |
| 2023 August | 133 | 19 | 152 |
| 2023 July | 97 | 33 | 130 |
| 2023 June | 100 | 29 | 129 |
| 2023 May | 82 | 45 | 127 |
| 2023 April | 67 | 28 | 95 |
| 2023 March | 121 | 36 | 157 |
| 2023 February | 99 | 32 | 131 |
| 2023 January | 98 | 17 | 115 |
| 2022 December | 133 | 45 | 178 |
| 2022 November | 98 | 42 | 140 |
| 2022 October | 116 | 39 | 155 |
| 2022 September | 111 | 46 | 157 |
| 2022 August | 103 | 55 | 158 |
| 2022 July | 114 | 48 | 162 |
| 2022 June | 113 | 52 | 165 |
| 2022 May | 131 | 63 | 194 |
| 2022 April | 144 | 17 | 161 |
| 2022 March | 175 | 25 | 200 |
| 2022 February | 155 | 23 | 178 |
| 2022 January | 248 | 39 | 287 |
| 2021 December | 299 | 36 | 335 |
| 2021 November | 357 | 29 | 386 |
| 2021 October | 183 | 35 | 218 |
| 2021 September | 146 | 34 | 180 |
| 2021 August | 178 | 23 | 201 |
| 2021 July | 230 | 40 | 270 |
| 2021 June | 224 | 30 | 254 |
| 2021 May | 407 | 37 | 444 |
| 2021 April | 1011 | 84 | 1095 |
| 2021 March | 499 | 54 | 553 |
| 2021 February | 742 | 83 | 825 |
| 2021 January | 381 | 51 | 432 |
| 2020 December | 438 | 52 | 490 |
| 2020 November | 520 | 51 | 571 |
| 2020 October | 299 | 43 | 342 |
| 2020 September | 262 | 63 | 325 |
| 2020 August | 343 | 52 | 395 |
| 2020 July | 577 | 66 | 643 |
| 2020 June | 805 | 100 | 905 |
| 2020 May | 1758 | 197 | 1955 |
| 2020 April | 88 | 21 | 109 |
Show all
